In response to the most recent report by IMARC Group, titled “Non-Invasive Prenatal Testing (NIPT) Market: International Trade Tendencies, Share, Measurement, Progress, Alternative and Forecast 2023-2028,” presents a complete evaluation of the business, which includes insights available on the market. The non-invasive prenatal testing market report additionally consists of competitor and regional evaluation, and modern developments available in the market. The international non-invasive prenatal testing market dimension reached US$ 3.4 Billion in 2022. Wanting ahead, IMARC Group expects the market to achieve US$ 8.5 Billion by 2028, exhibiting a development charge (CAGR) of 17.2% throughout 2023-2028.
Non-Invasive Prenatal Testing (NIPT) Market Overview:
Non-invasive prenatal testing (NIPT) refers to a screening technique that’s typically performed on pregnant girls to detect the dangers of particular genetic abnormalities within the fetus. It’s typically performed for fetal chromosomal aneuploidies to be able to analyze cell-free deoxyribonucleic acid (DNA) circulation in maternal blood. In addition to this, it’s broadly most popular over different screening processes, particularly for trisomy 21 and people who’re at a better danger of fetal chromosomal abnormalities. It entails a number of exams, together with ultrasound detection, cell-free DNA and fetal cells in maternal blood and biochemical screening exams.
Moreover, additionally it is used to find out genetic and chromosomal issues, reminiscent of triploidy aneuploidy, Patau, Jacob’s, down, Klinefelter, Turners, and Edwards syndromes. It’s extremely most popular to make an knowledgeable choice related to diagnostic testing whereas minimizing the necessity for precarious and invasive procedures. Consequently, it gives low-false optimistic charges with increased accuracy, sensitivity, and specificity whereas lowering the danger of miscarriage.
Request Free Pattern Report (Unique Provide on this report): https://www.imarcgroup.com/non-invasive-prenatal-testing-market/requestsample
International Non-Invasive Prenatal Testing Market Tendencies:
The rising beginning charge throughout the globe majorly drives the market. Coupled with the rising prevalence of fetal chromosomal abnormalities is among the main components driving the market. With the rising consciousness amongst dad and mom, the demand for early non-invasive prenatal testing (NIPT) is quickly growing, thereby impacting the market development.
Other than this, a number of initiatives undertaken by the governments of quite a few nations, together with the inclusion of NIPT in public well being insurance policies and funds allocation for average-risk pregnancies, are providing profitable alternatives to the important thing gamers. Since obstetricians are recommending non-invasive exams as an alternative choice to varied invasive strategies, together with the rising desire for preliminary diagnostic screening within the first trimester of being pregnant, this, in flip propelling the expansion of the market.
Moreover, continuous technological developments on the worldwide stage have inspired main gamers to closely spend money on novel applied sciences. For example, the widespread integration of synthetic intelligence (AI) and deep neural networks with NIPT to help healthcare professionals in decision-making in difficult-to-call instances and likewise assist in correct detection of aneuploidies and microdeletions within the fetus. A few of the different components driving the market development embrace rising well being consciousness amongst dad and mom, vital enhancements within the healthcare infrastructure, and continuous developments within the subject of next-generation sequencing (NGS).
Ask Analyst for Instantaneous Low cost and Obtain Full Report with TOC & Listing of Determine: https://www.imarcgroup.com/non-invasive-prenatal-testing-market
Key Market Segmentation:
High Firms In Non-Invasive Prenatal Testing Market:
- Agilent Applied sciences Inc.
- Berry Genetics Inc.
- BGI Genomics Co. Ltd.
- Eurofins LifeCodexx GmbH
- F. Hoffmann-La Roche AG
- GE Healthcare, Igenomix
- Illumina Inc.
- Laboratory Company
- Natera Inc.
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
- Yourgene Well being
Breakup by Product Sort:
Breakup by Take a look at Sort:
- Materni 21
Breakup by Expertise:
Breakup by Take a look at Sort:
- Ultrasound Detection
- Biochemical Screening Checks
- Cell-Free DNA in Maternal Plasma Checks
- Fetal Cells in Maternal Blood Checks
Breakup by Utility:
- Microdeletions Syndrome
Breakup by Finish-Consumer:
- Diagnostic Laboratories
Breakup by Area:
- North America (United States, Canada)
- Asia Pacific (Germany, France, United Kingdom, Italy, Spain, Others)
- Europe (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Center East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Different)
IMARC Group is a number one market analysis firm that gives administration technique and market analysis worldwide. We companion with shoppers in all sectors and areas to determine their highest-value alternatives, handle their most important challenges, and rework their companies.
IMARC’s info merchandise embrace main market, scientific, financial and technological developments for enterprise leaders in pharmaceutical, industrial, and excessive know-how organizations. Market forecasts and business evaluation for biotechnology, superior supplies, prescription drugs, meals and beverage, journey and tourism, nanotechnology and novel processing strategies are on the prime of the corporate’s experience.
134 N 4th St. Brooklyn, NY 11249, USA
E-mail: gross [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800